Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Johnson

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Plos One|March 1, 2023
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenograftsRex H Lee, Ritu Roy, Hua Li, et al.
Molecular Cancer Therapeutics|May 21, 2020
Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that <i>PTEN</i> Loss Contributes to Cetuximab Resistance in Head and Neck CancerHiroki Izumi, Zhiyong Wang, Yusuke Goto, et al.
Laryngoscope Investigative Otolaryngology|February 22, 2021
Clinical trials optimizing investigator and self-collection of buccal cells for RNA yieldJessica L Geiger, Elizabeth D Cedars, Yan Zang, et al.
Molecular Pharmacology|March 8, 2008
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neckAmanda L Boehm, Malabika Sen, Raja Seethala, et al.
Head & Neck|October 31, 2025
Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
Targeting Stat3 abrogates EGFR inhibitor resistance in cancerMalabika Sen, Sonali Joyce, Mary Panahandeh, et al.
Head & Neck|September 30, 2024
CYLD Alterations Are Associated With Metastasis and Poor Prognosis in Human Papilloma Virus-Positive Head and Neck CancerZhibin Cui, Hyunseok Kang, Hua Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagyYan Zang, Sufi M Thomas, Elena T Chan, et al.
Autophagy|September 22, 2012
The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4Yan Zang, Sufi M Thomas, Elena T Chan, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Plos One|March 1, 2023
Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenograftsRex H Lee, Ritu Roy, Hua Li, et al.
Molecular Cancer Therapeutics|May 21, 2020
Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that <i>PTEN</i> Loss Contributes to Cetuximab Resistance in Head and Neck CancerHiroki Izumi, Zhiyong Wang, Yusuke Goto, et al.
Laryngoscope Investigative Otolaryngology|February 22, 2021
Clinical trials optimizing investigator and self-collection of buccal cells for RNA yieldJessica L Geiger, Elizabeth D Cedars, Yan Zang, et al.
Molecular Pharmacology|March 8, 2008
Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neckAmanda L Boehm, Malabika Sen, Raja Seethala, et al.
Head & Neck|October 31, 2025
Human Papilloma Virus Does Not Fully Inactivate p53 Cellular Activity in HNSCCJovanka Gencel-Augusto, Hua Li, Liam C Woerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2012
Targeting Stat3 abrogates EGFR inhibitor resistance in cancerMalabika Sen, Sonali Joyce, Mary Panahandeh, et al.
Head & Neck|September 30, 2024
CYLD Alterations Are Associated With Metastasis and Poor Prognosis in Human Papilloma Virus-Positive Head and Neck CancerZhibin Cui, Hyunseok Kang, Hua Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2012
Carfilzomib and ONX 0912 inhibit cell survival and tumor growth of head and neck cancer and their activities are enhanced by suppression of Mcl-1 or autophagyYan Zang, Sufi M Thomas, Elena T Chan, et al.
Autophagy|September 22, 2012
The next generation proteasome inhibitors carfilzomib and oprozomib activate prosurvival autophagy via induction of the unfolded protein response and ATF4Yan Zang, Sufi M Thomas, Elena T Chan, et al.
Biochemical and Biophysical Research Communications|March 28, 2025
Neddylation as a target in PIK3CA-mutated head and neck cancerShorook Naara, Zhibin Cui, Adila Izgutdina, et al.
Pageof 11